NO20071044L - Doseformer med enteraltbelagte tablettkjerner - Google Patents
Doseformer med enteraltbelagte tablettkjernerInfo
- Publication number
- NO20071044L NO20071044L NO20071044A NO20071044A NO20071044L NO 20071044 L NO20071044 L NO 20071044L NO 20071044 A NO20071044 A NO 20071044A NO 20071044 A NO20071044 A NO 20071044A NO 20071044 L NO20071044 L NO 20071044L
- Authority
- NO
- Norway
- Prior art keywords
- coated tablet
- present
- dosage forms
- patient
- tablet cores
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59148204P | 2004-07-26 | 2004-07-26 | |
| US59182004P | 2004-07-27 | 2004-07-27 | |
| PCT/US2005/026610 WO2006012634A1 (fr) | 2004-07-26 | 2005-07-26 | Formes posologiques avec comprimé à noyau pelliculé gastro-résistant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071044L true NO20071044L (no) | 2007-02-23 |
Family
ID=35229812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071044A NO20071044L (no) | 2004-07-26 | 2007-02-23 | Doseformer med enteraltbelagte tablettkjerner |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060153918A1 (fr) |
| EP (1) | EP1663167A1 (fr) |
| KR (1) | KR20070036797A (fr) |
| AU (1) | AU2005266882A1 (fr) |
| BR (1) | BRPI0513598A (fr) |
| CA (1) | CA2575006A1 (fr) |
| EA (1) | EA200700158A1 (fr) |
| IL (1) | IL180883A0 (fr) |
| MX (1) | MX2007001058A (fr) |
| NO (1) | NO20071044L (fr) |
| WO (1) | WO2006012634A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007056570A2 (fr) * | 2005-11-07 | 2007-05-18 | Teva Pharmaceutical Industries Ltd. | Compositions de levodopa |
| US9265732B2 (en) | 2006-03-06 | 2016-02-23 | Pozen Inc. | Dosage forms for administering combinations of drugs |
| CN101410095B (zh) * | 2006-03-06 | 2015-07-01 | 波曾公司 | 施用组合药物的剂型 |
| WO2007133583A2 (fr) * | 2006-05-09 | 2007-11-22 | Mallinckrodt Inc. | Formes posologiques solides à libération modifiée d'ordre zéro |
| US20100112053A1 (en) * | 2007-01-15 | 2010-05-06 | Kissei Pharmaceutical Co., Ltd. | Gastric retention-type sustained-release levodopa preparation |
| EP1987816A1 (fr) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate d'un sel de rasagiline en combinaison avec un agent inactive soluble dans l'eau |
| SG187455A1 (en) * | 2008-01-11 | 2013-02-28 | Teva Pharma | Rasagiline formulations, their preparation and use |
| US20100189791A1 (en) * | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline malate formulation |
| WO2011096953A1 (fr) * | 2010-02-05 | 2011-08-11 | Cenerx Biopharma, Inc. | Formulation orale d'antidépresseur avec une charge réduite en excipients |
| KR102092002B1 (ko) * | 2012-04-27 | 2020-03-23 | 메르크 파텐트 게엠베하 | 코팅이 있는 정제 및 이의 제조 |
| ES2698611T3 (es) | 2012-07-12 | 2019-02-05 | SpecGx LLC | Composiciones farmacéuticas disuasorias del abuso y de liberación prolongada |
| WO2016174664A1 (fr) | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Compositions à désintégration par voie orale |
| ES2641308B1 (es) * | 2016-05-05 | 2018-09-11 | Products & Technology, S.L. | Comprimidos de metilfenidato de liberación retardada |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL109170C (fr) * | 1958-02-03 | |||
| GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
| DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
| US5071607A (en) * | 1990-01-31 | 1991-12-10 | Alza Corporatino | Method and apparatus for forming a hole in a drug dispensing device |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5994377A (en) * | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| US6756056B2 (en) * | 1997-04-08 | 2004-06-29 | Alan A. Rubin | Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa |
| US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| CA2461870A1 (fr) * | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Formes de dosage a liberation modifiee |
| US6863901B2 (en) * | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
| WO2003057136A2 (fr) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique |
| CA2505861A1 (fr) * | 2002-11-12 | 2004-05-27 | Teva Pharmaceutical Industries Ltd. | Compositions pharmaceutiques et formes posologiques pour administration par voie buccale et sublinguale de tizanidine et methodes d'administration par voie buccale ou sublinguale |
| KR20080109101A (ko) * | 2003-10-20 | 2008-12-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레보도파의 지속적 효과를 위한 조성물 및 제형 |
-
2005
- 2005-07-26 EP EP05778376A patent/EP1663167A1/fr not_active Withdrawn
- 2005-07-26 MX MX2007001058A patent/MX2007001058A/es not_active Application Discontinuation
- 2005-07-26 CA CA002575006A patent/CA2575006A1/fr not_active Abandoned
- 2005-07-26 WO PCT/US2005/026610 patent/WO2006012634A1/fr not_active Ceased
- 2005-07-26 BR BRPI0513598-2A patent/BRPI0513598A/pt not_active IP Right Cessation
- 2005-07-26 KR KR1020077004143A patent/KR20070036797A/ko not_active Ceased
- 2005-07-26 US US11/190,766 patent/US20060153918A1/en not_active Abandoned
- 2005-07-26 EA EA200700158A patent/EA200700158A1/ru unknown
- 2005-07-26 AU AU2005266882A patent/AU2005266882A1/en not_active Abandoned
-
2007
- 2007-01-22 IL IL180883A patent/IL180883A0/en unknown
- 2007-02-23 NO NO20071044A patent/NO20071044L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2575006A1 (fr) | 2006-02-02 |
| US20060153918A1 (en) | 2006-07-13 |
| BRPI0513598A (pt) | 2008-05-13 |
| EP1663167A1 (fr) | 2006-06-07 |
| IL180883A0 (en) | 2007-07-04 |
| MX2007001058A (es) | 2007-04-16 |
| KR20070036797A (ko) | 2007-04-03 |
| EA200700158A1 (ru) | 2007-08-31 |
| AU2005266882A1 (en) | 2006-02-02 |
| WO2006012634A1 (fr) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071044L (no) | Doseformer med enteraltbelagte tablettkjerner | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
| ATE306266T1 (de) | Verbesserte verabreichungstechnik für multiple medikamentengaben | |
| EP1893182B8 (fr) | Formes posologiques orales contenant de la progesterone et procede de fabrication et d'utilisation desdites formes posologiques | |
| MX2007006212A (es) | Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular. | |
| NO20051414L (no) | Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger | |
| CY1112256T1 (el) | Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της | |
| BR0211198A (pt) | Composições farmacêuticas e seu uso | |
| WO2008142572A3 (fr) | Formulation de comprimé à libération contrôlée contenant de l'aluminométasilicate de magnésium | |
| NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| NO20073813L (no) | Kladribinregime for behandling av multippel sklerose | |
| DK1711169T3 (da) | Coatede mikrodepottabletter med venlafaxinhydrochlorid | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| BR0308305A (pt) | Fórmulas dosadas de liberação controlada | |
| MY146988A (en) | Fexofenadine suspension formulation | |
| WO2006040779A3 (fr) | Formule à matrice flottante gastrique à libération contrôlée contenant la substance imatinib | |
| DE602004016963D1 (en) | Therapeutisches system mit amoxicillin und clavulansäure | |
| SG169381A1 (en) | New citrate salt of an indole derivative and its pharmaceutical use | |
| SG145717A1 (en) | Composition for releasing a weak base for an extended period of time | |
| TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
| ATE401075T1 (de) | Cytisinehaltiges arzneimittel | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| BRPI0516545A (pt) | uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |